A study in MS patients focused on the effects of cannabidiol and ∆9-THC on TLR3 and TLR4 from peripheral blood mononuclear cells revealed anti-inflammatory responses since reduced expression of IFN-β was documented in both groups. Here, IFNB1 is linked to myeloid sarcoma.